Concepedia

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Jean Bourhis, Christian Sire, P. Gräff, Vincent Grégoire, P. Maingon, G. Calais, B. Géry, Laurent Martin, M. Alfonsi, Patrick Desprez,

The Lancet Oncology · 2012 · 382 citations · 23 references

DOI

Concepts

References

23

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

, , +9

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard et al. · Radiotherapy and Oncology · 2009 · 3K citations

, , +9

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

Jean Bourhis, C. Domenge, L. Designé · The Lancet · 2000 · 2.5K citations

, , +8

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

, , +13

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Jacques Bernier, Jay S. Cooper, Thomas F. Pajak et al. · Head & Neck · 2005 · 1.8K citations

, , +10